Evidence map›Paper›PMID 41349310›Full record

ArticleJournal of hazardous materials2026

Tiam1 up-regulation by long non-coding RNA ABHD11-AS1 sponging of miR-182-5p causes β-catenin pathway activation to promote hexavalent chromium lung carcinogenesis.

Zhuoyue Bi, Po-Shun Wang, Zulong Liu, Matthew L Finkelberg, Emily Li, David Carlson, Kenneth R Shroyer, Chengfeng Yang, Zhishan Wang

Abstract read
In one paragraph

Article in Journal of hazardous materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhuoyue BiStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.
Po-Shun WangStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.
Zulong LiuStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.
Matthew L FinkelbergStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.
Emily LiStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.
David CarlsonInstitute for Advanced Computational Science, Stony Brook University, Stony Brook, New York, USA; Genomics Core Facility, Stony Brook University, Stony Brook, New York, USA.
Kenneth R ShroyerStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.
Chengfeng YangStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.
Zhishan WangStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA. Electronic address: zhishan.wang@stonybrook.edu.

Funding

Dysregulations of functional RNA modifications and hexavalent chromium lungcarcinogenesisR01ES032787 · NIEHS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Chengfeng Yang · 2022 to 2026
$2.1M
MECHANISM OF HEXAVALENT CHROMIUM CARCINOGENESIS ROLE OF LONG NON-CODING RNA DYSREGULATIONR01ES029942 · NIEHS · UNIVERSITY OF KENTUCKY · PI YANG, CHENGFENG · 2019 to 2023
$1.8M
MGMT DOWN-REGULATION IN THE CARCINOGENICITY OF HEXAVALENT CHROMIUMR01ES029496 · NIEHS · UNIVERSITY OF KENTUCKY · PI WANG, ZHISHAN · 2019 to 2023
$1.7M
NIEHS NIH HHS R01 ES029496NIEHS NIH HHS R01 ES029942NIEHS NIH HHS R01 ES032787
6 · The paper itself

Abstract

Lung cancer is the deadliest cancer worldwide; however, its pathogenesis remains incompletely understood. Cigarette smoking is the principal risk factor for lung cancer, however, approximately 20 % of lung cancer cases occur in non-smokers, suggesting that additional etiological factors play important roles. Hexavalent chromium [Cr(VI)] is identified as a lung carcinogen and constitutes a significant etiological factor. This study explored the mechanisms of Cr(VI)-induced lung cancer using cell culture systems and genetically modified mouse models. Chronic Cr(VI) exposure upregulated the long non-coding RNA (lncRNA) ABHD11-AS1, which functions as a sponge for miR-182-5p causing its downregulation. MiR-182-5p downregulation increased the expression of its target gene, Tiam1. By using gain-of-function approaches, it was determined that miR-182-5p downregulation and Tiam1 upregulation contribute significantly to Cr(VI)-induced cell transformation and tumorigenesis. Furthermore, Tiam1 knockout abolished Cr(VI)-induced lung carcinogenesis in mice. Mechanistic studies revealed that Cr(VI)-activated Tiam1/Rac signaling inhibits glycogen synthase kinase 3 (GSK3), resulting in β-catenin stabilization, nuclear translocation, and transcriptional activation. These findings underscore the pivotal contribution of Tiam1 upregulation to lung cancer development. Given the pivotal role of β-catenin in oncogenesis, we conclude that ABHD11-AS1-mediated sponging of miR-182-5p leads to Tiam1 upregulation and β-catenin pathway activation, thereby promoting Cr(VI)-induced pulmonary carcinogenesis.

Indexed as

beta CateninChromiumLung NeoplasmsMicroRNAsRNA, Long NoncodingT-Lymphoma Invasion and Metastasis-inducing Protein 1AnimalsCarcinogenesisHumansMiceUp-Regulationbeta CateninChromiumchromium hexavalent ionMicroRNAsMirn182 microRNA, mouseRNA, Long NoncodingTiam1 protein, mouseT-Lymphoma Invasion and Metastasis-inducing Protein 1Hexavalent chromium [Cr(VI)]Long non-coding RNA ABHD11-AS1Lung cancerMiR-182–5pTiam1Wnt/β-catenin pathway

Identifiers

PMID41349310
PMCPMC12746611

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.